Related Experiment Videos
Very low cefotaxime concentrations select for hypermutable Streptococcus pneumoniae populations
María-Cristina Negri1, María-Isabel Morosini, María-Rosario Baquero
1Servicio de Microbiología, Hospital Ramón y Cajal, Madrid, Spain.
Antimicrobial Agents and Chemotherapy
|January 18, 2002
Summary
Low-dose cefotaxime selects for hypermutable Streptococcus pneumoniae strains. This increases the risk of developing further antibiotic resistance, such as to ciprofloxacin.
Area of Science:
- Microbiology
- Genetics
- Pharmacology
Background:
- The emergence of antibiotic resistance in Streptococcus pneumoniae is a significant public health concern.
- Hypermutable bacterial strains can accelerate the development of resistance.
- The role of sub-inhibitory antibiotic concentrations in selecting for hypermutators is not fully understood.
Purpose of the Study:
- To investigate the selection of hypermutable Streptococcus pneumoniae strains by low cefotaxime concentrations.
- To examine the impact of cefotaxime-induced hypermutation on the acquisition of secondary antibiotic resistance.
Main Methods:
- A mixed culture of a hypermutable hexA mutant and its isogenic wild-type Streptococcus pneumoniae strain was exposed to low cefotaxime concentrations.
- Selection and characterization of resistant variants.
- Determination of mutation frequencies for ciprofloxacin resistance in selected strains.
Main Results:
- The hypermutable hexA mutant strain was significantly selected even at very low cefotaxime concentrations.
- All selected variants carried a specific mutation (Thr550-->Ala) in the pbp2x gene.
- Cefotaxime-selected mutants exhibited a 10-fold higher mutation frequency for ciprofloxacin resistance.
Conclusions:
- Sub-lethal cefotaxime concentrations can select for hypermutable Streptococcus pneumoniae.
- Selection of hypermutators by one antibiotic can increase the risk of acquiring resistance to other antibiotics.
- This study models the potential for evolution of multi-drug resistance in bacteria.